JP2017061566A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017061566A5 JP2017061566A5 JP2016247753A JP2016247753A JP2017061566A5 JP 2017061566 A5 JP2017061566 A5 JP 2017061566A5 JP 2016247753 A JP2016247753 A JP 2016247753A JP 2016247753 A JP2016247753 A JP 2016247753A JP 2017061566 A5 JP2017061566 A5 JP 2017061566A5
- Authority
- JP
- Japan
- Prior art keywords
- crystalline genistein
- salt
- genistein
- therapeutic composition
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940045109 genistein Drugs 0.000 claims 9
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 claims 9
- 235000006539 genistein Nutrition 0.000 claims 9
- -1 genistein calcium salt Chemical class 0.000 claims 8
- 230000001225 therapeutic effect Effects 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 3
- 201000003883 Cystic fibrosis Diseases 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 208000037976 chronic inflammation Diseases 0.000 claims 2
- 230000006020 chronic inflammation Effects 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 201000007905 transthyretin amyloidosis Diseases 0.000 claims 2
- ZGUIQJAPZVGYCM-UHFFFAOYSA-N O.O.[K] Chemical compound O.O.[K] ZGUIQJAPZVGYCM-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 150000002272 genistein Chemical class 0.000 claims 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12177808P | 2008-12-11 | 2008-12-11 | |
| US12178708P | 2008-12-11 | 2008-12-11 | |
| US61/121,778 | 2008-12-11 | ||
| US61/121,787 | 2008-12-11 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015104213A Division JP6067781B2 (ja) | 2008-12-11 | 2015-05-22 | ゲニステインの結晶形 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017061566A JP2017061566A (ja) | 2017-03-30 |
| JP2017061566A5 true JP2017061566A5 (OSRAM) | 2017-08-03 |
Family
ID=42243089
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011540919A Expired - Fee Related JP5898958B2 (ja) | 2008-12-11 | 2009-12-11 | ゲニステインの結晶形 |
| JP2015104213A Expired - Fee Related JP6067781B2 (ja) | 2008-12-11 | 2015-05-22 | ゲニステインの結晶形 |
| JP2016247753A Pending JP2017061566A (ja) | 2008-12-11 | 2016-12-21 | ゲニステインの結晶形 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011540919A Expired - Fee Related JP5898958B2 (ja) | 2008-12-11 | 2009-12-11 | ゲニステインの結晶形 |
| JP2015104213A Expired - Fee Related JP6067781B2 (ja) | 2008-12-11 | 2015-05-22 | ゲニステインの結晶形 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US9012495B2 (OSRAM) |
| EP (1) | EP2373326B1 (OSRAM) |
| JP (3) | JP5898958B2 (OSRAM) |
| KR (2) | KR20110106355A (OSRAM) |
| CN (2) | CN104860913B (OSRAM) |
| AU (1) | AU2009324489B2 (OSRAM) |
| BR (1) | BRPI0923504A2 (OSRAM) |
| CA (1) | CA2746652C (OSRAM) |
| IL (2) | IL213473A (OSRAM) |
| WO (1) | WO2010068861A1 (OSRAM) |
| ZA (1) | ZA201105045B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2373326B1 (en) | 2008-12-11 | 2016-03-09 | Axcentua Pharmaceutucals AB | Crystalline forms of genistein |
| US7863325B2 (en) | 2008-12-11 | 2011-01-04 | Axcentua Pharmaceuticals Ab | Crystalline genistein sodium salt dihydrate |
| WO2011104667A1 (en) * | 2010-02-25 | 2011-09-01 | Anthem Biosciences Private Limited | Basic aminoacid salts of polyphenols |
| CN102442989B (zh) * | 2010-10-12 | 2015-04-08 | 上海睿智化学研究有限公司 | 一种金雀异黄素盐、其晶体及其制备方法 |
| CN102442991B (zh) * | 2010-10-12 | 2015-03-11 | 上海睿智化学研究有限公司 | 一种金雀异黄素维生素b6共晶、其晶体及其制备方法 |
| CN102442990B (zh) * | 2010-10-12 | 2015-03-11 | 上海睿智化学研究有限公司 | 一种金雀异黄素烟酰胺共晶、其晶体及其制备方法 |
| CN105963246B (zh) * | 2016-05-06 | 2018-12-25 | 荆楚理工学院 | 一种染料木素盐口服溶液剂及制备方法和应用 |
| CN105853350A (zh) * | 2016-05-24 | 2016-08-17 | 荆楚理工学院 | 一种染料木素溶液及制备方法和应用 |
| CN109666014A (zh) * | 2018-12-12 | 2019-04-23 | 荆门医药工业技术研究院 | 一种染料木素衍生物盐的制备方法及其应用 |
| US20240058298A1 (en) | 2020-12-03 | 2024-02-22 | Delta 4 Gmbh | Genistein for use in the treatment of focal segmental glomerulosclerosis (fsgs) |
| AU2023261942A1 (en) | 2022-04-28 | 2024-09-19 | GreenStone Biosciences, Inc. | Treatment of the adverse cardiovascular effects of cannabinoids |
| US20250170154A1 (en) | 2023-11-28 | 2025-05-29 | GreenStone Biosciences, Inc. | Genistein phosphate derivatives |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62201882A (ja) * | 1985-11-18 | 1987-09-05 | Yamanouchi Pharmaceut Co Ltd | イソフラボン誘導体 |
| USRE40792E1 (en) * | 1992-05-19 | 2009-06-23 | Novogen Research Pty Ltd | Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
| DE4331233A1 (de) * | 1993-09-15 | 1995-03-16 | Basf Ag | Verfahren zur Herstellung von Hydroxyoxaalkylmelaminen |
| US5569459A (en) * | 1995-02-15 | 1996-10-29 | Bio-Virus Research Incorporated | Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders |
| US5554519A (en) | 1995-08-07 | 1996-09-10 | Fermalogic, Inc. | Process of preparing genistein |
| PL179170B1 (pl) * | 1995-09-15 | 2000-07-31 | Inst Lekow | Nowe zwiazki,pochodne genisteiny PL PL PL PL |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| KR19990082463A (ko) | 1996-02-13 | 1999-11-25 | 돈 리사 로얄 | 혈관 내피 성장 인자 억제제로서의 퀴나졸린유도체 |
| AU719327B2 (en) | 1996-03-05 | 2000-05-04 | Astrazeneca Ab | 4-anilinoquinazoline derivatives |
| GB9613455D0 (en) * | 1996-06-27 | 1996-08-28 | Aston Molecules Ltd | Analogues or derivatives of quercetin |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| US5981775A (en) | 1998-09-16 | 1999-11-09 | Board Of Trustees Operating Michigan State University | Process for the preparation of isoflavones |
| US6194469B1 (en) * | 1998-12-11 | 2001-02-27 | Board Of Trustees Operating Michigan State Univeristy | Method for inhibiting cyclooxygenase and inflammation using cherry bioflavonoids |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| AUPQ520300A0 (en) * | 2000-01-21 | 2000-02-17 | Novogen Research Pty Ltd | Food product and process |
| EP1289952A1 (en) | 2000-05-31 | 2003-03-12 | AstraZeneca AB | Indole derivatives with vascular damaging activity |
| DE60010450T2 (de) * | 2000-06-16 | 2005-05-12 | Linnea S.A., Riazzino | Wasserlöslicher Komplex eines Ginkgo biloba-Extrakts, Verfahren zu dessen Herstellung und diesen enthaltende Zusammensetzung |
| WO2002008213A1 (en) | 2000-07-07 | 2002-01-31 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as angiogenesis inhibitors |
| MXPA02012905A (es) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Derivados de colquinol como agentes de dano vascular.. |
| US6541613B2 (en) * | 2000-12-15 | 2003-04-01 | Uyrex Corporation | Isoflavone derivatives |
| PL205635B1 (pl) * | 2001-04-09 | 2010-05-31 | Inst Farmaceutyczny | Nowe pochodne genisteiny i zawierające je środki farmaceutyczne |
| CN100348592C (zh) * | 2001-12-28 | 2007-11-14 | 中国人民解放军第二军医大学 | 3，7，8－三取代－5－羟基苯并－γ－吡喃酮类化合物及其制备方法 |
| US20040023981A1 (en) | 2002-07-24 | 2004-02-05 | Yu Ren | Salt forms with tyrosine kinase activity |
| US7528121B2 (en) | 2002-12-24 | 2009-05-05 | Astrazeneca Ab | Phosphonooxy quinazoline derivatives and their pharmaceutical use |
| EP1765379A4 (en) * | 2004-06-17 | 2009-05-27 | Transform Pharmaceuticals Inc | PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS AND RELEVANT USE METHOD |
| EP1618880B1 (en) * | 2004-07-20 | 2010-07-14 | Furfural Espanol, S.A. | Use of compounds derived from 2,3-dehydronaringenin for the treatment of inflammatory processes and pharmaceutical composition containing said derivatives |
| EP1853252B1 (en) * | 2005-02-15 | 2010-09-08 | DSM IP Assets B.V. | Compositions containing polysaccharides |
| US8951560B2 (en) * | 2005-06-29 | 2015-02-10 | Dsm Ip Assets B.V. | Isoflavone nanoparticles and use thereof |
| US20070037875A1 (en) * | 2005-08-11 | 2007-02-15 | The Scripps Research Institute | Genistein inhibition of transthyretin amyloidosis |
| WO2007061254A1 (en) * | 2005-11-25 | 2007-05-31 | B & C Biopharm. Co., Ltd. | Genistein derivatives and anti-fungal composition containing the same |
| EP2074223A4 (en) | 2006-09-15 | 2010-03-10 | Foldrx Pharmaceuticals Inc | TEST PROCEDURE FOR THE DETECTION OF PROTEINS IN THE NATIVE CONDITION AND FOR THE IDENTIFICATION OF THE STABILITY OF PROTEINS IN THE NATIVE CONDITION MODULATING COMPOUNDS |
| JP2008094751A (ja) * | 2006-10-11 | 2008-04-24 | Ono Pharmaceut Co Ltd | プランルカスト水和物含有医薬組成物 |
| EP2373326B1 (en) | 2008-12-11 | 2016-03-09 | Axcentua Pharmaceutucals AB | Crystalline forms of genistein |
-
2009
- 2009-12-11 EP EP09832607.7A patent/EP2373326B1/en not_active Not-in-force
- 2009-12-11 CN CN201510205311.6A patent/CN104860913B/zh not_active Expired - Fee Related
- 2009-12-11 WO PCT/US2009/067664 patent/WO2010068861A1/en not_active Ceased
- 2009-12-11 KR KR1020117016045A patent/KR20110106355A/ko not_active Ceased
- 2009-12-11 BR BRPI0923504-3A patent/BRPI0923504A2/pt not_active IP Right Cessation
- 2009-12-11 US US13/133,085 patent/US9012495B2/en not_active Expired - Fee Related
- 2009-12-11 CA CA2746652A patent/CA2746652C/en not_active Expired - Fee Related
- 2009-12-11 CN CN200980155203.5A patent/CN102292097B/zh not_active Expired - Fee Related
- 2009-12-11 AU AU2009324489A patent/AU2009324489B2/en not_active Ceased
- 2009-12-11 KR KR1020177021179A patent/KR101849059B1/ko not_active Expired - Fee Related
- 2009-12-11 JP JP2011540919A patent/JP5898958B2/ja not_active Expired - Fee Related
-
2011
- 2011-06-09 IL IL213473A patent/IL213473A/en not_active IP Right Cessation
- 2011-07-08 ZA ZA2011/05045A patent/ZA201105045B/en unknown
-
2014
- 2014-11-27 IL IL235943A patent/IL235943A0/en unknown
-
2015
- 2015-04-20 US US14/691,251 patent/US9492425B2/en not_active Expired - Fee Related
- 2015-05-22 JP JP2015104213A patent/JP6067781B2/ja not_active Expired - Fee Related
-
2016
- 2016-12-21 JP JP2016247753A patent/JP2017061566A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017061566A5 (OSRAM) | ||
| JP2015193630A5 (OSRAM) | ||
| JP2012512164A5 (OSRAM) | ||
| MX385731B (es) | Compuestos de biaril-monobactam y métodos de uso de los mismos para el tratamiento de infecciones bacterianas. | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| SA520411571B1 (ar) | مركبات كرومان مونوباكتام لعلاج العدوى البكتيرية | |
| JP2014507446A5 (OSRAM) | ||
| PH12015502628A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of disease | |
| WO2015187542A8 (en) | Histone deacetylase inhibitors and compositions and methods of use thereof | |
| JP2017524735A5 (OSRAM) | ||
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| WO2016164763A8 (en) | Compositions and methods for treating cns disorders | |
| EA201592255A1 (ru) | Производные пиразолопирролидин-4-она в качестве ингибиторов вет и их применение при лечении заболевания | |
| RU2018114480A (ru) | Соли и твердые формы монобактамного антибиотика | |
| JP2013507408A5 (OSRAM) | ||
| WO2019040106A3 (en) | COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES | |
| IL307992A (en) | Parasitic formulations containing isoxazoline and methods for treating blepharitis | |
| JP2015516419A5 (OSRAM) | ||
| CL2019000857A1 (es) | Compuestos heterocíclicos y su uso para prevenir o tratar las infecciones bacterianas. | |
| HK1212688A1 (zh) | 吡啶酮衍生物及其在治疗、改善或预防病毒疾病中的用途 | |
| MX2019002369A (es) | Compuestos para el tratamiento de enfermedades asociadas con una disfuncion mitocondrial. | |
| WO2018005444A3 (en) | Methods for treating cancer | |
| MX2019001007A (es) | Uso novedoso de nectinib y una sal farmaceuticamente aceptable del mismo en el tratamiento contra enfermedades. | |
| JP2016515550A5 (OSRAM) | ||
| MX2015008292A (es) | Derivados de naftiridinona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral. |